These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33043582)

  • 21. SF3B1 Mutation but Not Ring Sideroblasts Identifies a Specific Group of Myelodysplastic Syndrome-Refractory Cytopenia With Multilineage Dysplasia.
    Xiong B; Xue M; Yu Y; Wu S; Zuo X
    Clin Lymphoma Myeloma Leuk; 2020 May; 20(5):329-339.e3. PubMed ID: 32037286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes.
    Sallman DA; Komrokji R; Vaupel C; Cluzeau T; Geyer SM; McGraw KL; Al Ali NH; Lancet J; McGinniss MJ; Nahas S; Smith AE; Kulasekararaj A; Mufti G; List A; Hall J; Padron E
    Leukemia; 2016 Mar; 30(3):666-73. PubMed ID: 26514544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applications.
    Pellagatti A; Boultwood J
    Adv Biol Regul; 2017 Jan; 63():59-70. PubMed ID: 27639445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myelodysplastic syndrome with multilineage dysplasia evolving to acute myeloid leukemia: Noonan syndrome with c.218C>T mutation in PTPN11 gene.
    Shenoy RD; Yeshvanth SK; Prasada L H; Shenoy V; Shetty V
    Pediatr Blood Cancer; 2019 Feb; 66(2):e27527. PubMed ID: 30378271
    [No Abstract]   [Full Text] [Related]  

  • 25. Alteration of SF3B1 and SRSF2 Genes in Myelodysplastic Syndromes Patients in Upper Northern Thailand.
    Yimpak P; Tantiworawit A; Rattanathammethee T; Angsuchawan S; Laowatthanapong S; Tasuya W; Bumroongkit K
    Asian Pac J Cancer Prev; 2019 Apr; 20(4):1215-1221. PubMed ID: 31030497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatic
    Foy A; McMullin MF
    J Clin Pathol; 2019 Nov; 72(11):778-782. PubMed ID: 31473630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myelodysplastic syndrome/myeloproliferative neoplasm - ring sideroblast with myelofibrosis - A diagnostic dilemma/? A distinct entity.
    Talwar A; Bansal S; Bapna A; Sharma U
    Indian J Pathol Microbiol; 2021; 64(2):434-436. PubMed ID: 33851659
    [No Abstract]   [Full Text] [Related]  

  • 28. Letter to the Editor regarding the article "Prognostic significance of SF3B1 mutations in patients with myelodysplastic syndromes: A meta-analysis".
    Yang T; Wang L; Zhang Y
    Crit Rev Oncol Hematol; 2021 Jun; 162():103295. PubMed ID: 33992800
    [No Abstract]   [Full Text] [Related]  

  • 29.
    Mangaonkar AA; Lasho TL; Finke C; Ketterling RP; Reichard KK; McCullough K; Gangat N; Al-Kali A; Begna KH; Hogan WH; Litzow MR; Alkhateeb H; Shah M; Pardanani A; Tefferi A; Al Ali NH; Talati C; Sallman D; Padron E; Komrokji R; Patnaik MM
    Haematologica; 2022 May; 107(5):1189-1192. PubMed ID: 35142154
    [No Abstract]   [Full Text] [Related]  

  • 30. Myeloid Neoplasm With Germline Predisposition: A 2016 Update for Pathologists.
    Gao J; Gong S; Chen YH
    Arch Pathol Lab Med; 2019 Jan; 143(1):13-22. PubMed ID: 29372845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "Double-hit" ineffective erythropoiesis-concurrent β-thalassemia with α-gene triplication and myelodysplastic syndrome with SF3B1 mutation.
    Chen PH; Gorshein E; Tormey C; Siddon AJ; Perincheri S
    Am J Hematol; 2023 Jun; 98(6):984-988. PubMed ID: 36688500
    [No Abstract]   [Full Text] [Related]  

  • 32. The relation of SF3B1 mutation and intracellular iron in myelodysplastic syndrome with less than 5% bone marrow blasts.
    Ma L; Luo Y; Jiang L; Shen D; Li J; Xu W; Mei C; Zhou X; Ren Y; Ye L; Lu C; Jie J; Tong H
    Leuk Lymphoma; 2019 May; 60(5):1179-1186. PubMed ID: 30409066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of the WHO 2016 proposals for Myelodysplastic syndromes patients with the presence of ring sideroblasts but without excess blasts.
    Li Y; Cui R; Qin T; Xu Z; Zhang Y; Cai W; Cui W; Liu J; Li B; Xiao Z
    Br J Haematol; 2017 Sep; 178(5):813-816. PubMed ID: 27292319
    [No Abstract]   [Full Text] [Related]  

  • 34. Karyotype evolution and acquisition of FLT3 or RAS pathway alterations drive progression of myelodysplastic syndrome to acute myeloid leukemia.
    Meggendorfer M; de Albuquerque A; Nadarajah N; Alpermann T; Kern W; Steuer K; Perglerová K; Haferlach C; Schnittger S; Haferlach T
    Haematologica; 2015 Dec; 100(12):e487-90. PubMed ID: 26294738
    [No Abstract]   [Full Text] [Related]  

  • 35. Genetic Testing in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
    Nardi V; Hasserjian RP
    Surg Pathol Clin; 2016 Mar; 9(1):143-63. PubMed ID: 26940274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Frequency of SF3B1 Mutations in Thai Patients with Myelodysplastic Syndrome.
    Rujirachaivej P; Siriboonpiputtana T; Rerkamnuaychoke B; Magmuang S; Chareonsirisuthigul T; Boonsakan P; Petvises S; Sirirat T; Niparuck P; Chuncharunee S
    Asian Pac J Cancer Prev; 2018 Jul; 19(7):1825-1831. PubMed ID: 30049194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations in spliceosome genes in myelodysplastic neoplasms and their association to ring sideroblasts.
    Huber S; Haferlach T; Meggendorfer M; Hutter S; Hoermann G; Summerer I; Fuhrmann I; Baer C; Kern W; Haferlach C
    Leukemia; 2023 Feb; 37(2):500-502. PubMed ID: 36463343
    [No Abstract]   [Full Text] [Related]  

  • 38. Prognostic value and clinical feature of SF3B1 mutations in myelodysplastic syndromes: A meta-analysis.
    Tang Y; Miao M; Han S; Qi J; Wang H; Ruan C; Wu D; Han Y
    Crit Rev Oncol Hematol; 2019 Jan; 133():74-83. PubMed ID: 30661660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterisation of a compound in-cis GATA2 germline mutation in a pedigree presenting with myelodysplastic syndrome/acute myeloid leukemia with concurrent thrombocytopenia.
    Hahn CN; Brautigan PJ; Chong CE; Janssan A; Venugopal P; Lee Y; Tims AE; Horwitz MS; Klingler-Hoffmann M; Scott HS
    Leukemia; 2015 Aug; 29(8):1795-7. PubMed ID: 25676417
    [No Abstract]   [Full Text] [Related]  

  • 40. Recurrent mutations in multiple components of the SWI/SNF complex in myelodysplastic syndromes and acute myeloid leukaemia.
    Yao H; Huo L; Ping N; Liu H; Li H; Ding Z; Shen H; Xie J; Qiu Q; Ma L; Jiang A; Wang Q; Wu D; Yang X; Song Y; Chen S
    Br J Haematol; 2022 Jan; 196(2):441-444. PubMed ID: 34535894
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.